Главная Назад


Авторизация
Идентификатор пользователя / читателя
Пароль (для удалённых пользователей)
 

Вид поиска

Область поиска
в найденном
Найдено в других БД
Формат представления найденных документов:
библиографическое описание краткийполный
Отсортировать найденные документы по:
авторузаглавиюгоду изданиятипу документа
Поисковый запрос: (<.>S=РАСБУРИКАЗА<.>)
Общее количество найденных документов : 26
Показаны документы с 1 по 20
 1-20    21-26 
1.
Hoffmeister Rasburicase. Rekombinante Uratoxidase in der Therapie und Prophylaxe des Tumorlysesyndroms // Arzneimitteltherapie, 2002. Vol. 20, N 3.-С.65-67

2.
Goldman Stanton C. Recombinant urate oxidase (Rasburicase) and IV allopurinol for hyperuricemia in patients with acute tumor Lysis syndrome (ATLS) // Cancer Invest., 2003. Vol. 21, прил. 1.-С.93-94

3.
Goldman Stanton C. Recombinant urate oxidase (Rasburicase) and IV allopurinol for hyperuricemia in patients with acute tumor Lysis syndrome (ATLS) // Cancer Invest., 2003. Vol. 21, прил. 1.-С.93-94

4.
de Bont J.M. Management of hyperuricemia with Rasburicase review // Nucleosides , Nucleotides and Nucl. Acids, 2004. Vol. 23, N 8-9.-С.1431-1440

5.
Use of single-dose rasburicase in an obese female // Ann. Pharmacother., 2004. Vol. 38, N 9.-С.1428-1431

6.
Use of single-dose rasburicase in an obese female // Ann. Pharmacother., 2004. Vol. 38, N 9.-С.1428-1431

7.
Prophylaxe und differenzielle Therapie des Tumorlysesyndroms // DMW: Dtsch. med. Wochenschr., 2004. Vol. 129, N 25-26.-С.1440-1445

8.
Prophylaxe und differenzielle Therapie des Tumorlysesyndroms // DMW: Dtsch. med. Wochenschr., 2004. Vol. 129, N 25-26.-С.1440-1445

9.
de Bont J.M. Management of hyperuricemia with Rasburicase review // Nucleosides , Nucleotides and Nucl. Acids, 2004. Vol. 23, N 8-9.-С.1431-1440

10.
Browning Linda A. Hemolysis and methemoglobinemia secondary to rasburicase administration // Ann. Pharmacother., 2005. Vol. 39, N 11.-С.1932-1935

11.
Rasburicase for the management of tumor lysis syndrome in neonates // Ann. Pharmacother., 2006. Vol. 40, N 7-8.-С.1445-1450

12.
Single-dose rasburicase 6 mg in the management of tumor lysis syndrome in adults // Pharmacotherapy, 2006. Vol. 26, N 6.-С.806-812

13.
Single-dose rasburicase 6 mg in the management of tumor lysis syndrome in adults // Pharmacotherapy, 2006. Vol. 26, N 6.-С.806-812

14.
Reduced-dose rasburicase in the treatment of adults with hyperuricemia associated with malignancy // Pharmacotherapy, 2006. Vol. 26, N 2.-С.242-247

15.
Reduced-dose rasburicase in the treatment of adults with hyperuricemia associated with malignancy // Pharmacotherapy, 2006. Vol. 26, N 2.-С.242-247

16.
Rasburicase for the management of tumor lysis syndrome in neonates // Ann. Pharmacother., 2006. Vol. 40, N 7-8.-С.1445-1450

17.
Is rasburicase an effective alternative to allopurinol for management of hyperuricemia in renal failure patients? A double blind-randomized study // Eur. Rev. Med. and Parmacol. Sci., 2007. Vol. 11, N 3.-С.179-184

18.
Sood Amy R. Clarifying the role of rasburicase in tumor Lysis syndrome // Pharmacotherapy, 2007. Vol. 27, N 1.-С.111-121

19.
Sood Amy R. Clarifying the role of rasburicase in tumor Lysis syndrome // Pharmacotherapy, 2007. Vol. 27, N 1.-С.111-121

20.
Reeves David J. Evaluation of a single fixed dose of rasburicase 7.5 mg for the treatment of hyperuricemia in adults with cancer // Pharmacotherapy, 2008. Vol. 28, N 6.-С.685-690

 1-20    21-26 
 




© Международная Ассоциация пользователей и разработчиков электронных библиотек и новых информационных технологий
(Ассоциация ЭБНИТ)